In CKD patients, polymorphonuclear leukocytes (PMNs) and monocytes are activated, resulting in increased release of nicotinamide adenine dinucleotide phosphate (NADPH) oxidase and myeloperoxidase (MPO), which promotes the formation of ROS [110]. This evidence concerns the gene MPO and chronic kidney disease.